ReP USP - Resultado da busca

Filtros : "Hungria" "EESC-SEL" Removidos: " IFSC111" "Ciências da Reabilitação" "Machado, Sergio Antonio Spinola" "aku" "PLOS ONE" Limpar

Filtros

Collaboration
Normalized affiliation
Non normalized affiliation
- astrazeneca. (1)
- budapest university of technology and economics. (1)
- dana-farber cancer institute. (1)
- fundação faculdade regional de medicina de são josé do rio preto. são josé do rio preto, sp. (1)
- german center for lung research (1)

Countries of institutions of collaboration
- brasil (2)
- hungria (2)
- alemanha (1)
- bulgária (1)
- estados unidos (1)

Artigo de periodico
Power-sharing for dc microgrid with composite storage devices and voltage restoration without communication (2022)
Bastos, Renan Fernandes; Aguiar, Cassius Rossi de; Ballogh, Attila; Sütõ, Zoltán; Machado, Ricardo Quadros
Source: International Journal of Electrical Power & Energy Systems. Unidade: EESC
Assunto: ENGENHARIA ELÉTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Renan Fernandes et al. Power-sharing for dc microgrid with composite storage devices and voltage restoration without communication. International Journal of Electrical Power & Energy Systems, v. 138, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijepes.2021.107928. Acesso em: 08 jul. 2024.
APA
Bastos, R. F., Aguiar, C. R. de, Ballogh, A., Sütõ, Z., & Machado, R. Q. (2022). Power-sharing for dc microgrid with composite storage devices and voltage restoration without communication. International Journal of Electrical Power & Energy Systems, 138, 1-9. doi:10.1016/j.ijepes.2021.107928
NLM
Bastos RF, Aguiar CR de, Ballogh A, Sütõ Z, Machado RQ. Power-sharing for dc microgrid with composite storage devices and voltage restoration without communication [Internet]. International Journal of Electrical Power & Energy Systems. 2022 ; 138 1-9.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.ijepes.2021.107928
Vancouver
Bastos RF, Aguiar CR de, Ballogh A, Sütõ Z, Machado RQ. Power-sharing for dc microgrid with composite storage devices and voltage restoration without communication [Internet]. International Journal of Electrical Power & Energy Systems. 2022 ; 138 1-9.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.ijepes.2021.107928
Artigo de periodico
SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer (2017)
Soria, J. C.; Fülöp, A. ; Maciel, Carlos Dias ; Fischer, J. R.; Girotto, G.; Lago, S; Smith, E; Ostoros, G.; Eberhardt, W. E. E.; Lishkovska, P; Lovick, S.; Mariani, G.; McKeown, A; Kilgour, E; Smith, P; Bowen. K; Kohlmann, A; Carlile, D. J.; Jänne. P. A.
Source: Annals of Oncology. Unidade: EESC
Subjects: ONCOLOGIA, NEOPLASIAS PULMONARES, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIA, J. C. et al. SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. Annals of Oncology, v. 28, n. 12, p. 3028-3036, 2017Tradução . . Disponível em: http://dx.doi.org/10.1093/annonc/mdx628. Acesso em: 08 jul. 2024.
APA
Soria, J. C., Fülöp, A., Maciel, C. D., Fischer, J. R., Girotto, G., Lago, S., et al. (2017). SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. Annals of Oncology, 28( 12), 3028-3036. doi:10.1093/annonc/mdx628
NLM
Soria JC, Fülöp A, Maciel CD, Fischer JR, Girotto G, Lago S, Smith E, Ostoros G, Eberhardt WEE, Lishkovska P, Lovick S, Mariani G, McKeown A, Kilgour E, Smith P, Bowen. K, Kohlmann A, Carlile DJ, Jänne. P. A. SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer [Internet]. Annals of Oncology. 2017 ; 28( 12): 3028-3036.[citado 2024 jul. 08 ] Available from: http://dx.doi.org/10.1093/annonc/mdx628
Vancouver
Soria JC, Fülöp A, Maciel CD, Fischer JR, Girotto G, Lago S, Smith E, Ostoros G, Eberhardt WEE, Lishkovska P, Lovick S, Mariani G, McKeown A, Kilgour E, Smith P, Bowen. K, Kohlmann A, Carlile DJ, Jänne. P. A. SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer [Internet]. Annals of Oncology. 2017 ; 28( 12): 3028-3036.[citado 2024 jul. 08 ] Available from: http://dx.doi.org/10.1093/annonc/mdx628

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024